Health Catalyst ( (HCAT) ) has released its Q4 earnings. Here is a breakdown of the information Health Catalyst presented to its investors.
Health Catalyst, Inc. is a prominent provider of data and analytics technology and services for healthcare organizations, focusing on improving clinical, financial, and operational outcomes through its innovative solutions.
In its latest earnings report for the fourth quarter and full year 2024, Health Catalyst announced a total revenue of $307 million and an Adjusted EBITDA of $26 million, reflecting strong performance and growth in its Technology segment, which saw a 10% year-over-year increase.
Key financial highlights include a 6% increase in quarterly revenue to $79.6 million and a significant reduction in net loss by 32% year-over-year. The company also reported a 137% increase in Adjusted EBITDA for the year, alongside strategic leadership changes, including the addition of Dr. Jill Hoggard Green to the Board of Directors and promotions within the leadership team.
Looking ahead, Health Catalyst anticipates continued growth in 2025, with projected total revenue of $335 million and an increase in Adjusted EBITDA to approximately $41 million, driven by faster growth in its Technology segment compared to the overall business.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com